Cargando…
The independent adverse prognostic significance of 1q21 gain/amplification in newly diagnosed multiple myeloma patients
OBJECTIVE: 1q21 gain/amplification (1q21+) is a common abnormal karyotype in multiple myeloma, and its proportion in Chinese patients is much higher. If 1q21+ is included as one of the poor prognostic factors, it will greatly increase the proportion of high-risk patients in newly diagnosed multiple...
Autores principales: | You, Hongying, Jin, Song, Wu, Chunxiao, Wang, Qingqing, Yan, Shuang, Yao, Weiqin, Shi, Xiaolan, Shang, Jingjing, Yan, Lingzhi, Yao, Ying, Wang, Jing, Wang, Panfeng, Pan, Jinlan, Wu, Depei, Fu, Chengcheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585234/ https://www.ncbi.nlm.nih.gov/pubmed/36276097 http://dx.doi.org/10.3389/fonc.2022.938392 |
Ejemplares similares
-
The prognostic significance of circulating plasma cells in newly diagnosed multiple myeloma patients
por: Yao, Weiqin, et al.
Publicado: (2023) -
Busulfan/Cyclophosphamide Compared with Melphalan as a Conditioning Regimen for Autologous Transplantation of Multiple Myeloma: A Long-Term Assessment
por: Zhou, Shiyuan, et al.
Publicado: (2023) -
Sequential CD19 and BCMA‐specific CAR T‐cell treatment elicits sustained remission of relapsed and/or refractory myeloma
por: Yan, Lingzhi, et al.
Publicado: (2020) -
Successful treatment of marrow failure after CARTs for myeloma by the infusion of cryopreserved stem cells
por: Yan, Lingzhi, et al.
Publicado: (2019) -
Gain/Amplification of Chromosome Arm 1q21 in Multiple Myeloma
por: Hanamura, Ichiro
Publicado: (2021)